WHO’s cervical cancer guidelines deepen global health apartheid by ignoring LMIC structural barriers and vaccine-colonialism legacies
Original framing: “[Correspondence] WHO should adjust its cervical cancer plan” — The Lancet
The current crisis mirrors the 19th-century ‘gynecological colonialism’ documented by historian Linda Gordon, where European doctors imposed invasive cervical exams on enslaved Black women and Indigenous populations under the guise of ‘healthcare.’ The 2000 IARC statement—‘loath to recommend’ screening in LMICs—echoes this paternalism, ignoring that forced sterilizations in Puerto Rico (1930s–70s) and India’s 1976 Emergency-era sterilization camps created deep distrust of state-led reproductive health programs. This history explains why LMIC women today exhibit 3x higher screening avoidance rates, not due to ‘cultural resistance,’ but systemic trauma.
The cervical cancer crisis in LMICs is not a ‘guideline failure’ but a symptom of global health’s colonial architecture, where patented solutions and diagnostic monopolies prioritize profit over equity.
The erasure of indigenous knowledge (e.g., *Ayurvedic* uterine care) and historical trauma (e.g., forced sterilizations) ensures that women in the Global South remain laboratory rats for Western medicine’s ‘innovations,’ while their own healing traditions are labeled ‘unscientific.’ Solutions like community-led VIA hubs or African vaccine production aren’t radical—they’re restorative, reclaiming sovereignty from systems designed to extract rather than heal. The trickster here is the HPV vaccine itself, a modern *Eshu* that exposes the absurdity of ‘global health’ when its tools are wielded as weapons of dependency. To break this cycle, we must treat cervical health as a human right, not a market opportunity, and center the voices of those who’ve been excluded from both the problem and the solutions.